Voeltzke, Kai
Scharov, Katerina
Funk, Cornelius Maximilian http://orcid.org/0000-0002-0837-3237
Kahler, Alisa http://orcid.org/0000-0001-8841-0490
Picard, Daniel
Hauffe, Laura
Orth, Martin F.
Remke, Marc
Esposito, Irene
Kirchner, Thomas
Schramm, Alexander http://orcid.org/0000-0001-7670-7529
Rotblat, Barak
Grünewald, Thomas G. P.
Reifenberger, Guido
Leprivier, Gabriel http://orcid.org/0000-0002-2299-8989
Article History
Received: 19 January 2022
Revised: 10 March 2022
Accepted: 18 March 2022
First Online: 4 April 2022
Competing interests
: TK received honoraria for Consulting/Advisory by Amgen, AstraZeneca, BMS, Merck KGaA, MSD, Novartis, Pfizer, Roche, for Research Funding by Merck KGaA and Roche; for talks by Merck KGaA, AstraZeneca. The other authors declare no conflict of interest.